AT-04, a novel peptibody with ability to clear neuropathic fibrillar aggregates in the Alzheimer’s disease brain
April 11, 2023
Researchers from Attralus Inc. reported preclinical data for AT-04, a novel peptibody designed to bind neuropathologic fibrillar aggregates in the brains of patients with Alzheimer’s disease (AD).
